医生常常提起的肿瘤分期具体是怎么回事

2016-05-24 佚名 消化病科普

说到肿瘤,医生最常谈到的一个词“分期”究竟是怎么回事。肿瘤分期可不是早期中期晚期这么简单,这篇文章简单介绍一下肿瘤分期的一些相关概念:对于肿瘤而言,分期到底意味着什么,有什么作用,又是怎么确定的呢?

说到肿瘤,医生最常谈到的一个词“分期”究竟是怎么回事。肿瘤分期可不是早期中期晚期这么简单,这篇文章简单介绍一下肿瘤分期的一些相关概念:对于肿瘤而言,分期到底意味着什么,有什么作用,又是怎么确定的呢?


什么是肿瘤分期?

简单来说肿瘤分期是用来评价肿瘤在体内生长程度的分级标准,常常用来描述肿瘤的侵犯、扩散程度和评估肿瘤的预后以及指导治疗。肿瘤分期有许多种不同方法,其中TNM分期作为国际标准被广泛接受,通过TNM三个指标来反应该肿瘤的特性(恶性肿瘤侵袭转移范围、进展程度等)。其中T(Tumor)指原发肿瘤的大小或浸润深度、N(Node)指淋巴结转移情况、M(Metastasis)指远处转移。

T、N、M每个指标还有具体细分。以T为例,Tx表明原发肿瘤无法评估,T0意为无原发肿瘤的证据,Tis说明是原位癌。T1,T2,T3和T4表示原发肿瘤逐级增大。N与M也可以进行类似的分级,用以标注淋巴结及远处的转移情况。最终,根据T/N/M的情况可以综合判断出患者的分期(即第I期至第IV期)状况。

T、N、M这三个元素基于客观的测量指标,几乎适用于全身各个部位的肿瘤,符合各种类型、各个层面的医疗环境的需要,而且在定义期别时需要开展的诊断项目易于施行,因而TNM分期成为世界范围内使用最广泛的分期系统。我们平时谈到的,I、II、III、IV期临床分期,就是通过TNM三个指标组合的基础上划出特定的分期。每种肿瘤根据其各自的特点I-IV期的划定具体的TNM指标略有不同。


比如,一位大肠腺癌患者的分期为T1N0M0,这就表示其肿瘤仅侵犯到黏膜下层,无淋巴结转移,亦无远处转移,综合这些指标可以判断出该患者的肿瘤是分期为I期的大肠癌。


分期如何确定

分期的确定需要利用内镜检查、影像学检查、手术探查及其他相关检查的资料方能进行综合判断。

影像学检查:通过CT或磁共振可初步确定肿瘤的部位、大小以及是否已转移至淋巴结或身体其他组织和器官处。医生还可以通过触诊明确有无淋巴结转移,是最简单直接的办法。

手术探查:术中进一步证实影像学评估的结果,手术过程直接判断肿瘤大小、部分以及是否侵犯到淋巴结及周边组织等。

术后病理报告:术后将切除下来的肿瘤进行病理评估,准确评估肿瘤大小、生长情况及细胞学类型,以及肿瘤切缘是否完整等信息。


为什么要搞一个肿瘤分期?

若没有分期这种比较客观的评价方式来给肿瘤分门别类,医生在讨论如何治疗肿瘤时,只能较早期、较晚期、较严重等主观色彩较浓的字眼来描述肿瘤,显然不够严谨。因此采用一种客观可测量的方法对患者的病情进行非门别类,判断出了肿瘤的分期按照治疗规范、治疗指南进行治疗和处理,有据可依。

肿瘤分期提供了一个客观评价标准,能为临床医师提供准确的患者分层管理依据,是选择辅助治疗方案、提高治疗效果的基本前提。肿瘤在不同分期有不同的治疗原则:比如经评估后某肿瘤属于早期,只需要手术完整切除即可;如果评估后肿瘤属于中晚期,手术切除后还需要化疗;而再晚期的病人是先化疗降期再考虑手术,还是只能行姑息化疗。而定制这些治疗方案需要在准确肿瘤分期的前提下。

并且分期是预测患者转归和预后的重要指标:比如,有的人得了结肠癌手术切除后活了十几年,有的人查出了肿瘤没多久就去世了,同样一种病差距竟然如此之大,这是为什么呢,因为分期不同。总的来说IV期的病人五年生存率很低,而I期的病人绝大多数都能获得治愈,因为分期越早说明发现的越早,治疗效果越好。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (10)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1740294, encodeId=8f7a1e40294b6, content=<a href='/topic/show?id=94dc8283e23' target=_blank style='color:#2F92EE;'>#肿瘤分期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82837, encryptionId=94dc8283e23, topicName=肿瘤分期)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cac734724454, createdName=12498c32m79暂无昵称, createdTime=Fri Feb 17 21:14:00 CST 2017, time=2017-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=138103, encodeId=c135138103a2, content=拜读,好文, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Fri Sep 30 14:43:00 CST 2016, time=2016-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88219, encodeId=a0f888219a3, content=再次学习 普及一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=61191606034, createdName=mym86538653, createdTime=Thu Jun 02 07:46:00 CST 2016, time=2016-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=87734, encodeId=c00b8e7344e, content=原来如此, beContent=null, objectType=article, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f9f21613855, createdName=lsblb, createdTime=Tue May 31 09:05:00 CST 2016, time=2016-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=87735, encodeId=d6588e7357e, content=原来如此, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f9f21613855, createdName=lsblb, createdTime=Tue May 31 09:05:00 CST 2016, time=2016-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=87078, encodeId=f04c8e07896, content=再次强化学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Pw2csslt7CukWiabqiblnQAbAss3ANsjUWZKUgN2n3JyJDHOJJAxibetNCiaEh70YckbPPTELyyStMZ8T3Q340icNSXgj72MowgTC/0, createdBy=188f1666747, createdName=1de00086m73(暂无匿称), createdTime=Wed May 25 09:08:00 CST 2016, time=2016-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=87034, encodeId=57678e034e7, content=的确这样, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Wed May 25 07:46:00 CST 2016, time=2016-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=87033, encodeId=20608e033a6, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Wed May 25 07:45:00 CST 2016, time=2016-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=86959, encodeId=0d1286959a8, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160804/IMG57A2EF131ACE72300.jpg, createdBy=a2811610046, createdName=黄庆, createdTime=Tue May 24 19:39:00 CST 2016, time=2016-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=86915, encodeId=53cc8691532, content=写得很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRtsiaTZlHWSsNf4cI6gKwvQDhYzlnoMEsMu95mc1bt5OYcOfnu4lsgAYJqbEvZ6PZExCA0iaglcXyk/0, createdBy=ba411724689, createdName=wxsession7c2379b3, createdTime=Tue May 24 11:22:00 CST 2016, time=2016-05-24, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1740294, encodeId=8f7a1e40294b6, content=<a href='/topic/show?id=94dc8283e23' target=_blank style='color:#2F92EE;'>#肿瘤分期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82837, encryptionId=94dc8283e23, topicName=肿瘤分期)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cac734724454, createdName=12498c32m79暂无昵称, createdTime=Fri Feb 17 21:14:00 CST 2017, time=2017-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=138103, encodeId=c135138103a2, content=拜读,好文, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Fri Sep 30 14:43:00 CST 2016, time=2016-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88219, encodeId=a0f888219a3, content=再次学习 普及一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=61191606034, createdName=mym86538653, createdTime=Thu Jun 02 07:46:00 CST 2016, time=2016-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=87734, encodeId=c00b8e7344e, content=原来如此, beContent=null, objectType=article, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f9f21613855, createdName=lsblb, createdTime=Tue May 31 09:05:00 CST 2016, time=2016-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=87735, encodeId=d6588e7357e, content=原来如此, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f9f21613855, createdName=lsblb, createdTime=Tue May 31 09:05:00 CST 2016, time=2016-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=87078, encodeId=f04c8e07896, content=再次强化学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Pw2csslt7CukWiabqiblnQAbAss3ANsjUWZKUgN2n3JyJDHOJJAxibetNCiaEh70YckbPPTELyyStMZ8T3Q340icNSXgj72MowgTC/0, createdBy=188f1666747, createdName=1de00086m73(暂无匿称), createdTime=Wed May 25 09:08:00 CST 2016, time=2016-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=87034, encodeId=57678e034e7, content=的确这样, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Wed May 25 07:46:00 CST 2016, time=2016-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=87033, encodeId=20608e033a6, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Wed May 25 07:45:00 CST 2016, time=2016-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=86959, encodeId=0d1286959a8, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160804/IMG57A2EF131ACE72300.jpg, createdBy=a2811610046, createdName=黄庆, createdTime=Tue May 24 19:39:00 CST 2016, time=2016-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=86915, encodeId=53cc8691532, content=写得很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRtsiaTZlHWSsNf4cI6gKwvQDhYzlnoMEsMu95mc1bt5OYcOfnu4lsgAYJqbEvZ6PZExCA0iaglcXyk/0, createdBy=ba411724689, createdName=wxsession7c2379b3, createdTime=Tue May 24 11:22:00 CST 2016, time=2016-05-24, status=1, ipAttribution=)]
    2016-09-30 1e10c84am36(暂无匿称)

    拜读,好文

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1740294, encodeId=8f7a1e40294b6, content=<a href='/topic/show?id=94dc8283e23' target=_blank style='color:#2F92EE;'>#肿瘤分期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82837, encryptionId=94dc8283e23, topicName=肿瘤分期)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cac734724454, createdName=12498c32m79暂无昵称, createdTime=Fri Feb 17 21:14:00 CST 2017, time=2017-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=138103, encodeId=c135138103a2, content=拜读,好文, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Fri Sep 30 14:43:00 CST 2016, time=2016-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88219, encodeId=a0f888219a3, content=再次学习 普及一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=61191606034, createdName=mym86538653, createdTime=Thu Jun 02 07:46:00 CST 2016, time=2016-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=87734, encodeId=c00b8e7344e, content=原来如此, beContent=null, objectType=article, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f9f21613855, createdName=lsblb, createdTime=Tue May 31 09:05:00 CST 2016, time=2016-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=87735, encodeId=d6588e7357e, content=原来如此, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f9f21613855, createdName=lsblb, createdTime=Tue May 31 09:05:00 CST 2016, time=2016-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=87078, encodeId=f04c8e07896, content=再次强化学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Pw2csslt7CukWiabqiblnQAbAss3ANsjUWZKUgN2n3JyJDHOJJAxibetNCiaEh70YckbPPTELyyStMZ8T3Q340icNSXgj72MowgTC/0, createdBy=188f1666747, createdName=1de00086m73(暂无匿称), createdTime=Wed May 25 09:08:00 CST 2016, time=2016-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=87034, encodeId=57678e034e7, content=的确这样, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Wed May 25 07:46:00 CST 2016, time=2016-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=87033, encodeId=20608e033a6, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Wed May 25 07:45:00 CST 2016, time=2016-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=86959, encodeId=0d1286959a8, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160804/IMG57A2EF131ACE72300.jpg, createdBy=a2811610046, createdName=黄庆, createdTime=Tue May 24 19:39:00 CST 2016, time=2016-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=86915, encodeId=53cc8691532, content=写得很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRtsiaTZlHWSsNf4cI6gKwvQDhYzlnoMEsMu95mc1bt5OYcOfnu4lsgAYJqbEvZ6PZExCA0iaglcXyk/0, createdBy=ba411724689, createdName=wxsession7c2379b3, createdTime=Tue May 24 11:22:00 CST 2016, time=2016-05-24, status=1, ipAttribution=)]
    2016-06-02 mym86538653

    再次学习 普及一下

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1740294, encodeId=8f7a1e40294b6, content=<a href='/topic/show?id=94dc8283e23' target=_blank style='color:#2F92EE;'>#肿瘤分期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82837, encryptionId=94dc8283e23, topicName=肿瘤分期)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cac734724454, createdName=12498c32m79暂无昵称, createdTime=Fri Feb 17 21:14:00 CST 2017, time=2017-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=138103, encodeId=c135138103a2, content=拜读,好文, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Fri Sep 30 14:43:00 CST 2016, time=2016-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88219, encodeId=a0f888219a3, content=再次学习 普及一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=61191606034, createdName=mym86538653, createdTime=Thu Jun 02 07:46:00 CST 2016, time=2016-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=87734, encodeId=c00b8e7344e, content=原来如此, beContent=null, objectType=article, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f9f21613855, createdName=lsblb, createdTime=Tue May 31 09:05:00 CST 2016, time=2016-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=87735, encodeId=d6588e7357e, content=原来如此, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f9f21613855, createdName=lsblb, createdTime=Tue May 31 09:05:00 CST 2016, time=2016-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=87078, encodeId=f04c8e07896, content=再次强化学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Pw2csslt7CukWiabqiblnQAbAss3ANsjUWZKUgN2n3JyJDHOJJAxibetNCiaEh70YckbPPTELyyStMZ8T3Q340icNSXgj72MowgTC/0, createdBy=188f1666747, createdName=1de00086m73(暂无匿称), createdTime=Wed May 25 09:08:00 CST 2016, time=2016-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=87034, encodeId=57678e034e7, content=的确这样, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Wed May 25 07:46:00 CST 2016, time=2016-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=87033, encodeId=20608e033a6, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Wed May 25 07:45:00 CST 2016, time=2016-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=86959, encodeId=0d1286959a8, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160804/IMG57A2EF131ACE72300.jpg, createdBy=a2811610046, createdName=黄庆, createdTime=Tue May 24 19:39:00 CST 2016, time=2016-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=86915, encodeId=53cc8691532, content=写得很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRtsiaTZlHWSsNf4cI6gKwvQDhYzlnoMEsMu95mc1bt5OYcOfnu4lsgAYJqbEvZ6PZExCA0iaglcXyk/0, createdBy=ba411724689, createdName=wxsession7c2379b3, createdTime=Tue May 24 11:22:00 CST 2016, time=2016-05-24, status=1, ipAttribution=)]
    2016-05-31 lsblb

    原来如此

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1740294, encodeId=8f7a1e40294b6, content=<a href='/topic/show?id=94dc8283e23' target=_blank style='color:#2F92EE;'>#肿瘤分期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82837, encryptionId=94dc8283e23, topicName=肿瘤分期)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cac734724454, createdName=12498c32m79暂无昵称, createdTime=Fri Feb 17 21:14:00 CST 2017, time=2017-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=138103, encodeId=c135138103a2, content=拜读,好文, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Fri Sep 30 14:43:00 CST 2016, time=2016-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88219, encodeId=a0f888219a3, content=再次学习 普及一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=61191606034, createdName=mym86538653, createdTime=Thu Jun 02 07:46:00 CST 2016, time=2016-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=87734, encodeId=c00b8e7344e, content=原来如此, beContent=null, objectType=article, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f9f21613855, createdName=lsblb, createdTime=Tue May 31 09:05:00 CST 2016, time=2016-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=87735, encodeId=d6588e7357e, content=原来如此, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f9f21613855, createdName=lsblb, createdTime=Tue May 31 09:05:00 CST 2016, time=2016-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=87078, encodeId=f04c8e07896, content=再次强化学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Pw2csslt7CukWiabqiblnQAbAss3ANsjUWZKUgN2n3JyJDHOJJAxibetNCiaEh70YckbPPTELyyStMZ8T3Q340icNSXgj72MowgTC/0, createdBy=188f1666747, createdName=1de00086m73(暂无匿称), createdTime=Wed May 25 09:08:00 CST 2016, time=2016-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=87034, encodeId=57678e034e7, content=的确这样, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Wed May 25 07:46:00 CST 2016, time=2016-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=87033, encodeId=20608e033a6, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Wed May 25 07:45:00 CST 2016, time=2016-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=86959, encodeId=0d1286959a8, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160804/IMG57A2EF131ACE72300.jpg, createdBy=a2811610046, createdName=黄庆, createdTime=Tue May 24 19:39:00 CST 2016, time=2016-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=86915, encodeId=53cc8691532, content=写得很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRtsiaTZlHWSsNf4cI6gKwvQDhYzlnoMEsMu95mc1bt5OYcOfnu4lsgAYJqbEvZ6PZExCA0iaglcXyk/0, createdBy=ba411724689, createdName=wxsession7c2379b3, createdTime=Tue May 24 11:22:00 CST 2016, time=2016-05-24, status=1, ipAttribution=)]
    2016-05-31 lsblb

    原来如此

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1740294, encodeId=8f7a1e40294b6, content=<a href='/topic/show?id=94dc8283e23' target=_blank style='color:#2F92EE;'>#肿瘤分期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82837, encryptionId=94dc8283e23, topicName=肿瘤分期)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cac734724454, createdName=12498c32m79暂无昵称, createdTime=Fri Feb 17 21:14:00 CST 2017, time=2017-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=138103, encodeId=c135138103a2, content=拜读,好文, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Fri Sep 30 14:43:00 CST 2016, time=2016-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88219, encodeId=a0f888219a3, content=再次学习 普及一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=61191606034, createdName=mym86538653, createdTime=Thu Jun 02 07:46:00 CST 2016, time=2016-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=87734, encodeId=c00b8e7344e, content=原来如此, beContent=null, objectType=article, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f9f21613855, createdName=lsblb, createdTime=Tue May 31 09:05:00 CST 2016, time=2016-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=87735, encodeId=d6588e7357e, content=原来如此, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f9f21613855, createdName=lsblb, createdTime=Tue May 31 09:05:00 CST 2016, time=2016-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=87078, encodeId=f04c8e07896, content=再次强化学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Pw2csslt7CukWiabqiblnQAbAss3ANsjUWZKUgN2n3JyJDHOJJAxibetNCiaEh70YckbPPTELyyStMZ8T3Q340icNSXgj72MowgTC/0, createdBy=188f1666747, createdName=1de00086m73(暂无匿称), createdTime=Wed May 25 09:08:00 CST 2016, time=2016-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=87034, encodeId=57678e034e7, content=的确这样, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Wed May 25 07:46:00 CST 2016, time=2016-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=87033, encodeId=20608e033a6, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Wed May 25 07:45:00 CST 2016, time=2016-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=86959, encodeId=0d1286959a8, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160804/IMG57A2EF131ACE72300.jpg, createdBy=a2811610046, createdName=黄庆, createdTime=Tue May 24 19:39:00 CST 2016, time=2016-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=86915, encodeId=53cc8691532, content=写得很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRtsiaTZlHWSsNf4cI6gKwvQDhYzlnoMEsMu95mc1bt5OYcOfnu4lsgAYJqbEvZ6PZExCA0iaglcXyk/0, createdBy=ba411724689, createdName=wxsession7c2379b3, createdTime=Tue May 24 11:22:00 CST 2016, time=2016-05-24, status=1, ipAttribution=)]
    2016-05-25 1de00086m73(暂无匿称)

    再次强化学习

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1740294, encodeId=8f7a1e40294b6, content=<a href='/topic/show?id=94dc8283e23' target=_blank style='color:#2F92EE;'>#肿瘤分期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82837, encryptionId=94dc8283e23, topicName=肿瘤分期)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cac734724454, createdName=12498c32m79暂无昵称, createdTime=Fri Feb 17 21:14:00 CST 2017, time=2017-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=138103, encodeId=c135138103a2, content=拜读,好文, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Fri Sep 30 14:43:00 CST 2016, time=2016-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88219, encodeId=a0f888219a3, content=再次学习 普及一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=61191606034, createdName=mym86538653, createdTime=Thu Jun 02 07:46:00 CST 2016, time=2016-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=87734, encodeId=c00b8e7344e, content=原来如此, beContent=null, objectType=article, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f9f21613855, createdName=lsblb, createdTime=Tue May 31 09:05:00 CST 2016, time=2016-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=87735, encodeId=d6588e7357e, content=原来如此, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f9f21613855, createdName=lsblb, createdTime=Tue May 31 09:05:00 CST 2016, time=2016-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=87078, encodeId=f04c8e07896, content=再次强化学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Pw2csslt7CukWiabqiblnQAbAss3ANsjUWZKUgN2n3JyJDHOJJAxibetNCiaEh70YckbPPTELyyStMZ8T3Q340icNSXgj72MowgTC/0, createdBy=188f1666747, createdName=1de00086m73(暂无匿称), createdTime=Wed May 25 09:08:00 CST 2016, time=2016-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=87034, encodeId=57678e034e7, content=的确这样, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Wed May 25 07:46:00 CST 2016, time=2016-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=87033, encodeId=20608e033a6, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Wed May 25 07:45:00 CST 2016, time=2016-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=86959, encodeId=0d1286959a8, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160804/IMG57A2EF131ACE72300.jpg, createdBy=a2811610046, createdName=黄庆, createdTime=Tue May 24 19:39:00 CST 2016, time=2016-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=86915, encodeId=53cc8691532, content=写得很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRtsiaTZlHWSsNf4cI6gKwvQDhYzlnoMEsMu95mc1bt5OYcOfnu4lsgAYJqbEvZ6PZExCA0iaglcXyk/0, createdBy=ba411724689, createdName=wxsession7c2379b3, createdTime=Tue May 24 11:22:00 CST 2016, time=2016-05-24, status=1, ipAttribution=)]
    2016-05-25 milkshark

    的确这样

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1740294, encodeId=8f7a1e40294b6, content=<a href='/topic/show?id=94dc8283e23' target=_blank style='color:#2F92EE;'>#肿瘤分期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82837, encryptionId=94dc8283e23, topicName=肿瘤分期)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cac734724454, createdName=12498c32m79暂无昵称, createdTime=Fri Feb 17 21:14:00 CST 2017, time=2017-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=138103, encodeId=c135138103a2, content=拜读,好文, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Fri Sep 30 14:43:00 CST 2016, time=2016-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88219, encodeId=a0f888219a3, content=再次学习 普及一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=61191606034, createdName=mym86538653, createdTime=Thu Jun 02 07:46:00 CST 2016, time=2016-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=87734, encodeId=c00b8e7344e, content=原来如此, beContent=null, objectType=article, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f9f21613855, createdName=lsblb, createdTime=Tue May 31 09:05:00 CST 2016, time=2016-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=87735, encodeId=d6588e7357e, content=原来如此, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f9f21613855, createdName=lsblb, createdTime=Tue May 31 09:05:00 CST 2016, time=2016-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=87078, encodeId=f04c8e07896, content=再次强化学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Pw2csslt7CukWiabqiblnQAbAss3ANsjUWZKUgN2n3JyJDHOJJAxibetNCiaEh70YckbPPTELyyStMZ8T3Q340icNSXgj72MowgTC/0, createdBy=188f1666747, createdName=1de00086m73(暂无匿称), createdTime=Wed May 25 09:08:00 CST 2016, time=2016-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=87034, encodeId=57678e034e7, content=的确这样, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Wed May 25 07:46:00 CST 2016, time=2016-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=87033, encodeId=20608e033a6, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Wed May 25 07:45:00 CST 2016, time=2016-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=86959, encodeId=0d1286959a8, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160804/IMG57A2EF131ACE72300.jpg, createdBy=a2811610046, createdName=黄庆, createdTime=Tue May 24 19:39:00 CST 2016, time=2016-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=86915, encodeId=53cc8691532, content=写得很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRtsiaTZlHWSsNf4cI6gKwvQDhYzlnoMEsMu95mc1bt5OYcOfnu4lsgAYJqbEvZ6PZExCA0iaglcXyk/0, createdBy=ba411724689, createdName=wxsession7c2379b3, createdTime=Tue May 24 11:22:00 CST 2016, time=2016-05-24, status=1, ipAttribution=)]
    2016-05-25 milkshark

    值得学习

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=1740294, encodeId=8f7a1e40294b6, content=<a href='/topic/show?id=94dc8283e23' target=_blank style='color:#2F92EE;'>#肿瘤分期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82837, encryptionId=94dc8283e23, topicName=肿瘤分期)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cac734724454, createdName=12498c32m79暂无昵称, createdTime=Fri Feb 17 21:14:00 CST 2017, time=2017-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=138103, encodeId=c135138103a2, content=拜读,好文, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Fri Sep 30 14:43:00 CST 2016, time=2016-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88219, encodeId=a0f888219a3, content=再次学习 普及一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=61191606034, createdName=mym86538653, createdTime=Thu Jun 02 07:46:00 CST 2016, time=2016-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=87734, encodeId=c00b8e7344e, content=原来如此, beContent=null, objectType=article, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f9f21613855, createdName=lsblb, createdTime=Tue May 31 09:05:00 CST 2016, time=2016-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=87735, encodeId=d6588e7357e, content=原来如此, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f9f21613855, createdName=lsblb, createdTime=Tue May 31 09:05:00 CST 2016, time=2016-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=87078, encodeId=f04c8e07896, content=再次强化学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Pw2csslt7CukWiabqiblnQAbAss3ANsjUWZKUgN2n3JyJDHOJJAxibetNCiaEh70YckbPPTELyyStMZ8T3Q340icNSXgj72MowgTC/0, createdBy=188f1666747, createdName=1de00086m73(暂无匿称), createdTime=Wed May 25 09:08:00 CST 2016, time=2016-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=87034, encodeId=57678e034e7, content=的确这样, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Wed May 25 07:46:00 CST 2016, time=2016-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=87033, encodeId=20608e033a6, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Wed May 25 07:45:00 CST 2016, time=2016-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=86959, encodeId=0d1286959a8, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160804/IMG57A2EF131ACE72300.jpg, createdBy=a2811610046, createdName=黄庆, createdTime=Tue May 24 19:39:00 CST 2016, time=2016-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=86915, encodeId=53cc8691532, content=写得很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRtsiaTZlHWSsNf4cI6gKwvQDhYzlnoMEsMu95mc1bt5OYcOfnu4lsgAYJqbEvZ6PZExCA0iaglcXyk/0, createdBy=ba411724689, createdName=wxsession7c2379b3, createdTime=Tue May 24 11:22:00 CST 2016, time=2016-05-24, status=1, ipAttribution=)]
    2016-05-24 黄庆

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=1740294, encodeId=8f7a1e40294b6, content=<a href='/topic/show?id=94dc8283e23' target=_blank style='color:#2F92EE;'>#肿瘤分期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82837, encryptionId=94dc8283e23, topicName=肿瘤分期)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cac734724454, createdName=12498c32m79暂无昵称, createdTime=Fri Feb 17 21:14:00 CST 2017, time=2017-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=138103, encodeId=c135138103a2, content=拜读,好文, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Fri Sep 30 14:43:00 CST 2016, time=2016-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88219, encodeId=a0f888219a3, content=再次学习 普及一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=61191606034, createdName=mym86538653, createdTime=Thu Jun 02 07:46:00 CST 2016, time=2016-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=87734, encodeId=c00b8e7344e, content=原来如此, beContent=null, objectType=article, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f9f21613855, createdName=lsblb, createdTime=Tue May 31 09:05:00 CST 2016, time=2016-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=87735, encodeId=d6588e7357e, content=原来如此, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f9f21613855, createdName=lsblb, createdTime=Tue May 31 09:05:00 CST 2016, time=2016-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=87078, encodeId=f04c8e07896, content=再次强化学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Pw2csslt7CukWiabqiblnQAbAss3ANsjUWZKUgN2n3JyJDHOJJAxibetNCiaEh70YckbPPTELyyStMZ8T3Q340icNSXgj72MowgTC/0, createdBy=188f1666747, createdName=1de00086m73(暂无匿称), createdTime=Wed May 25 09:08:00 CST 2016, time=2016-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=87034, encodeId=57678e034e7, content=的确这样, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Wed May 25 07:46:00 CST 2016, time=2016-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=87033, encodeId=20608e033a6, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Wed May 25 07:45:00 CST 2016, time=2016-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=86959, encodeId=0d1286959a8, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160804/IMG57A2EF131ACE72300.jpg, createdBy=a2811610046, createdName=黄庆, createdTime=Tue May 24 19:39:00 CST 2016, time=2016-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=86915, encodeId=53cc8691532, content=写得很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRtsiaTZlHWSsNf4cI6gKwvQDhYzlnoMEsMu95mc1bt5OYcOfnu4lsgAYJqbEvZ6PZExCA0iaglcXyk/0, createdBy=ba411724689, createdName=wxsession7c2379b3, createdTime=Tue May 24 11:22:00 CST 2016, time=2016-05-24, status=1, ipAttribution=)]
    2016-05-24 wxsession7c2379b3

    写得很好

    0

相关资讯

院士领衔扭转食管癌防治尴尬局面

我国是世界上食管癌发病率最高的国家之一。然而,上世纪90年代,我国食管癌患者的5年生存率仅为30.4%,远低于国际平均水平;到本世纪初,我国尚未建立高效、敏感的早期筛查技术,早诊早治目标人群也未确定;由于缺乏本土的规范化治疗指南,我国食管癌治疗策略只能照搬美国,治疗水平难以提高。 如今,食管癌防治的尴尬局面正在扭转。由中国科学院院士、中国医学科学院肿瘤医院院长赫捷领衔的研究团队,历时